{
     "PMID": "18207142",
     "OWN": "NLM",
     "STAT": "MEDLINE",
     "DCOM": "20080620",
     "LR": "20170220",
     "IS": "0014-4886 (Print) 0014-4886 (Linking)",
     "VI": "210",
     "IP": "2",
     "DP": "2008 Apr",
     "TI": "Anti-apoptotic therapy with a Tat fusion protein protects against excitotoxic insults in vitro and in vivo.",
     "PG": "602-7",
     "LID": "10.1016/j.expneurol.2007.12.008 [doi]",
     "AB": "A number of gene therapy approaches have been developed for protecting neurons from necrotic neurological insults. Such therapies are limited by the need for transcription and translation of the protective protein, delaying therapeutic impact. As an alternative, we explore the neuroprotective potential of protein therapy, using a fusion protein comprised of the death-suppressing BH4 domain of the Bcl-xL protein and the protein transduction domain of the human immunodeficiency virus Tat protein. This fusion protein decreased neurotoxicity caused by the excitotoxins glutamate and kainic acid in primary hippocampal cultures, and decreased hippocampal damage in vivo in an excitotoxic seizure model.",
     "FAU": [
          "Ju, Kevin L",
          "Manley, Nathan C",
          "Sapolsky, Robert M"
     ],
     "AU": [
          "Ju KL",
          "Manley NC",
          "Sapolsky RM"
     ],
     "AD": "Department of Biological Sciences, Stanford University, Stanford, CA 94305-5020, USA.",
     "LA": [
          "eng"
     ],
     "GR": [
          "P01 NS037520/NS/NINDS NIH HHS/United States",
          "R01 AG020633/AG/NIA NIH HHS/United States",
          "NS37520/NS/NINDS NIH HHS/United States"
     ],
     "PT": [
          "Journal Article",
          "Research Support, N.I.H., Extramural",
          "Research Support, Non-U.S. Gov't"
     ],
     "DEP": "20071223",
     "PL": "United States",
     "TA": "Exp Neurol",
     "JT": "Experimental neurology",
     "JID": "0370712",
     "RN": [
          "0 (Gene Products, tat)",
          "0 (Recombinant Proteins)",
          "0 (bcl-X Protein)",
          "3KX376GY7L (Glutamic Acid)",
          "SIV03811UC (Kainic Acid)"
     ],
     "SB": "IM",
     "MH": [
          "Animals",
          "Apoptosis/drug effects/*physiology",
          "Cells, Cultured",
          "Disease Models, Animal",
          "Drug Interactions",
          "Embryo, Mammalian",
          "Gene Products, tat/biosynthesis/*therapeutic use",
          "Glutamic Acid/toxicity",
          "Hippocampus/cytology",
          "Kainic Acid/toxicity",
          "Male",
          "Neuroglia/drug effects",
          "Neurons/drug effects",
          "Neurotoxicity Syndromes/*drug therapy/etiology",
          "Rats",
          "Rats, Sprague-Dawley",
          "Recombinant Proteins/biosynthesis/*therapeutic use",
          "bcl-X Protein/metabolism/*therapeutic use"
     ],
     "PMC": "PMC4782922",
     "MID": [
          "NIHMS46614"
     ],
     "EDAT": "2008/01/22 09:00",
     "MHDA": "2008/06/21 09:00",
     "CRDT": [
          "2008/01/22 09:00"
     ],
     "PHST": [
          "2006/08/09 00:00 [received]",
          "2007/11/20 00:00 [revised]",
          "2007/12/10 00:00 [accepted]",
          "2008/01/22 09:00 [pubmed]",
          "2008/06/21 09:00 [medline]",
          "2008/01/22 09:00 [entrez]"
     ],
     "AID": [
          "S0014-4886(07)00476-1 [pii]",
          "10.1016/j.expneurol.2007.12.008 [doi]"
     ],
     "PST": "ppublish",
     "SO": "Exp Neurol. 2008 Apr;210(2):602-7. doi: 10.1016/j.expneurol.2007.12.008. Epub 2007 Dec 23.",
     "term": "hippocampus"
}